| Monash home | About Monash | Faculties | Campuses | Contact Monash |
| Staff directory | A-Z index | Site map |
| Monash home | About Monash | Faculties | Campuses | Contact Monash |
| Staff directory | A-Z index | Site map |
|
|
ActivitiesNewsNews 2009
News 2008
NAB 2008 Business Awards Winners News 2007 Article: Unis breakdown language barrier between science, business
Source: The Age, Tues 29 May, 2007 Emmanuel Churchley’s PwC Placement
I previously completed Bachelor of Applied Science (Honours) that focussed on Exercise Science. During this degree I worked at Victorian Institute of Sport, Hawthorn Football Club and had my research published. After completing this degree, I was looking for a way to incorporate my science knowledge with business skills, which lead me to undertaking the Master of Business (Commercialising Science & Technology). Through the experiences and knowledge gained during this year, I have been offered a position at PricewaterhouseCoopers in the Performance Improvement - Health division. This position will involve working with members from within this division and from other divisions, in order to address the needs of clients in the Health industry. Thursday 4 October, 2007 
Did you know?Private, arm's length investors (often called "business angels") provide most of the start up capital for early stage businesses. The Ocean Tomo 300® Patent Index (OT300) is the first index based on the value of intellectual property, and represents a diversified portfolio of 300 companies that own the most valuable patents relative to their book value. At the end of November 2008 the broad US stock market index (S&P500) was below its level of 10 years earlier while the OT300 was about 40% higher. (See http://www.oceantomo.com/index_ot300.html). The superior performance continues to date (March 18) in 2009 As of Friday 28 November 2008, the AFR Share Tables (http://www.afr.com/home/tables.aspx? ) list 80 companies in the Pharmaceutical and Biotechnology Industry Group and the 40 smallest of these each had a market value of less than A$10 million. The total value of all 40 companies is only $170 million. The Intersuisse Biotechnology Index (http://www.intersuisse.com.au/standard.asp?pg=33 ) declined 43% between 1st November 2007 and the 14th November 2008. Is it a time for bargain hunting or will we see spring cleaning in the Australian biotech sector? Of the world's 1062 billionaires in 2008, there are 14 Australian citizens. Health R&D provides returns to Australia of 117%, exceeded only by mining and wholesale/retail of the sectors considered in The Australian Society of Medical Research report Exceptional Returns - The Value of Investing in Health R&D in Australia II. http://www.asmr.org.au/ExceptII08ABSUM.pdf In the year to September 2006 Australia added to its foreign debt by importing $3.9 billion more medicinal and pharmaceutical products than it exported. Source: Australian Bureau of Statistics In the 21 years since 1986, Australian Biotechnology shares gave the greatest return of all Australian Sharemarket industry sectors. Source: Sydney Morning Herald, January 12, 2007 Thomas Edison, inventor of the electric light, received "venture capital" from the famous financier J P Morgan. Source: "Morgan - American Financier", Jean Strouse, Random House 1999. In 2007 over half a billion Australian dollars of new venture capital fund commitments were raised in Australia. Source: AVCAL Yearbook 2007 Events - 2007, 2008 and 2009
|
